| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
35,202 |
32,828 |
$3.43M |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
24,810 |
9,300 |
$2.11M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15,519 |
14,561 |
$1.08M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,779 |
6,509 |
$610K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
6,325 |
6,122 |
$560K |
| 99215 |
Prolong outpt/office vis |
4,131 |
3,875 |
$533K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,795 |
4,526 |
$401K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
8,862 |
3,448 |
$378K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,360 |
2,288 |
$223K |
| 90837 |
Psychotherapy, 53 minutes with patient |
2,356 |
1,091 |
$208K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
1,816 |
1,756 |
$126K |
| 99499 |
|
4,786 |
4,506 |
$104K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
13,720 |
12,770 |
$100K |
| 99177 |
|
14,844 |
14,280 |
$75K |
| 99429 |
|
4,110 |
3,838 |
$71K |
| 96127 |
|
16,326 |
14,039 |
$66K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,439 |
1,366 |
$50K |
| D0120 |
Periodic oral evaluation - established patient |
2,068 |
1,932 |
$43K |
| 90686 |
|
3,037 |
2,936 |
$42K |
| 97533 |
|
1,018 |
466 |
$42K |
| D9999 |
Unspecified adjunctive procedure, by report |
1,964 |
1,831 |
$39K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
282 |
269 |
$36K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,053 |
1,008 |
$35K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
398 |
391 |
$34K |
| 90670 |
|
1,849 |
1,741 |
$25K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,317 |
1,288 |
$25K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
962 |
893 |
$18K |
| 97166 |
|
273 |
271 |
$16K |
| 97165 |
|
287 |
261 |
$14K |
| 92523 |
|
125 |
125 |
$14K |
| 97130 |
|
607 |
239 |
$10K |
| 97129 |
|
735 |
277 |
$9K |
| 92551 |
|
1,289 |
1,228 |
$9K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
456 |
423 |
$8K |
| 90698 |
|
760 |
713 |
$8K |
| 99381 |
|
102 |
88 |
$8K |
| 90791 |
Psychiatric diagnostic evaluation |
91 |
86 |
$8K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
274 |
124 |
$8K |
| 40819 |
|
55 |
51 |
$8K |
| 41115 |
|
69 |
65 |
$6K |
| 90677 |
|
516 |
458 |
$6K |
| 99173 |
|
4,003 |
3,812 |
$6K |
| 90633 |
|
425 |
402 |
$5K |
| 36416 |
|
811 |
768 |
$5K |
| D1206 |
Topical application of fluoride varnish |
291 |
246 |
$4K |
| 96161 |
|
2,409 |
2,169 |
$4K |
| 87634 |
|
60 |
59 |
$4K |
| 90710 |
|
289 |
262 |
$4K |
| 90697 |
|
220 |
183 |
$4K |
| 0071A |
|
93 |
93 |
$3K |
| 99383 |
|
32 |
31 |
$3K |
| 69210 |
|
140 |
121 |
$3K |
| 90834 |
Psychotherapy, 45 minutes with patient |
43 |
31 |
$3K |
| 90651 |
|
261 |
252 |
$3K |
| 85018 |
|
1,105 |
1,055 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
171 |
165 |
$2K |
| 90681 |
|
158 |
142 |
$2K |
| 83655 |
|
196 |
189 |
$2K |
| 99188 |
|
226 |
218 |
$2K |
| 80061 |
Lipid panel |
166 |
162 |
$2K |
| 0072A |
|
51 |
51 |
$2K |
| 90744 |
|
187 |
167 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
25 |
25 |
$1K |
| 99382 |
|
13 |
12 |
$981.63 |
| 88720 |
|
178 |
122 |
$770.11 |
| 90734 |
|
77 |
76 |
$694.12 |
| 90723 |
|
94 |
91 |
$663.29 |
| 90647 |
|
79 |
76 |
$472.34 |
| 90656 |
|
147 |
138 |
$442.19 |
| 90619 |
|
16 |
13 |
$290.41 |
| 90707 |
|
31 |
29 |
$269.15 |
| 90688 |
|
40 |
39 |
$235.68 |
| 90715 |
|
33 |
33 |
$193.78 |
| 81002 |
|
45 |
43 |
$132.57 |
| 90716 |
|
12 |
12 |
$116.80 |
| 96160 |
|
81 |
79 |
$109.85 |
| 81003 |
|
14 |
14 |
$27.20 |
| 2014F |
|
15 |
15 |
$25.00 |
| 99072 |
|
2,272 |
1,147 |
$0.00 |
| 91307 |
|
231 |
218 |
$0.00 |
| 99024 |
|
14 |
14 |
$0.00 |